Delivery Order SPE2D018D0005-SPE2D025F0259
Award Date 3/5/25
Potential Completion Date 4/16/26
Potential Value $69K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract is for the supply of Anti-A Bioclone 15x10ml, a critical medical diagnostic product, with a ceiling value of $1,832.54 and a period of performance through March 25, 2025. The contract is a fixed-price agreement with economic price adjustment and does not have a set-aside designation,...
- This is a firm fixed-price federal contract award to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Defense Health Agency. The $22,000.68 contract is for medical supplies and services, including clinical chemistry analyzers, immunoassay systems, blood typing instruments, and related consumables to support medical testing and diagnostic capabilities across federal healthcare institutions. The award is not associated...
- This is a delivery order contract awarded by the Defense agency's Medical Supply Chain organization to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract is for the supply of anti-S 1x3ml medical supplies, with a ceiling value of $1,670.66 and a period of performance through January 30, 2025. The contract has a fixed price with economic price adjustment pricing type and was not set aside for any special program....
- This is a federal contract award from the Medical Supply Chain (an alternate name for the Defense Agency), valued at $1,305.93, awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Delivery Order, with a fixed price and economic price adjustment pricing type, and an ultimate completion date of June 20, 2025. It does not have a set-aside designation. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that specializes...
- This is a delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The $186,396.12 firm fixed-price contract is for the delivery of ortho-clinical reagents and consumables, including CPT lease and maintenance, with an ultimate completion date of December 31, 2020. The contract is not set aside and was awarded under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule,...
- This is a $1,255.63 fixed-price delivery order awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The contract is for the supply of "ANTI-M 1X5ML" medical products, with a period of performance through April 23, 2025. The contract does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a key supplier of sophisticated...
- This is a definitive contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract, valued at $880,348.70, is for the provision of clinical chemistry reagents under CLIN 0001. The contract has a firm fixed price structure and an ultimate completion date of January 20, 2030. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and a manufacturer of goods, and...
- This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
- This contract was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The firm fixed price contract, valued at $63,640.26, is for the delivery of unspecified "other medical" products. The contract does not have a set-aside designation and is scheduled to be completed by April 30, 2024. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture that has provided a range of medical...
- This is a $1,849.78 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Defense Health Agency (DHA). The contract is for the provision of 4567880985 ! BLOOD GROUPING SERUM, with a period of performance ending on May 1, 2025. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture and a manufacturer of goods, primarily supplying critical medical diagnostic equipment and associated reagents to various federal...